Opium-Induced Bowel Dysfunction: A hospital survey in two academic centers of Iran
School of Medicine Students' Journal,
Vol. 4 No. 1 (2022),
https://doi.org/10.22037/smsj.v4i1.38831
Abstract
Background and aim: Opioids abuse is associated with several gastrointestinal side effects. We evaluated the prevalence of gastrointestinal symptoms in OIBD in hospitalized patients in different wards of Shahid Beheshti University of Medical Sciences (SBMU) hospitals. This study aimed to investigate patients' frequency symptoms treated with opioids and opium addicts and their derivatives.
Materials and Methods: The present study is a descriptive study conducted from April 2018 to October 2018. Direct interviews with the study population were performed for data collection. Their information, symptoms, and complaints were checked.
Results: Among the gastrointestinal symptoms, constipation was the most common symptom (59.3%). This pattern is followed by bloating (28.6%), heartburn (27.1%), abdominal pain (25.7%), dysphagia (22.9%), gastroesophageal reflux disease (22.1%), nausea (12.1%), and vomiting (7.9 %) and diarrhea (5 %) were the next prevalent symptoms, respectively.
Conclusion: Finally, our study showed that OBID symptoms are present in most opioid users and most of these people suffer from constipation. Also, the type of substance consumed by the person, the duration of continuous use and cigarette smoking play a role in the incidence of these symptoms.
- Gastrointestinal symptoms, Constipation, Opioids, Addiction, OIBD
How to Cite
References
2. Camilleri, M., et al., Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid‐induced constipation. Neurogastroenterology & Motility, 2014. 26(10): p. 1386-1395.
3. Ketwaroo, G.A., V. Cheng, and A. Lembo, Opioid-induced bowel dysfunction. Current gastroenterology reports, 2013. 15(9): p. 344.
4. Morlion, B., K.E. Clemens, and W. Dunlop, Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone. Clinical drug investigation, 2015. 35(1): p. 1-11.
5. Ahmadi, B., et al., Prevalence of narcotic bowel syndrome in opioid abusers in Iran. Middle East journal of digestive diseases, 2014. 6(4): p. 208.
6. Kurlander, J.E. and D.A. Drossman, Diagnosis and treatment of narcotic bowel syndrome. Nature Reviews Gastroenterology & Hepatology, 2014. 11(7): p. 410-418.
7. Müller-Lissner, S., et al., Opioid-induced constipation and bowel dysfunction: a clinical guideline. Pain Medicine, 2017. 18(10): p. 1837-1863.
8. Cook, S., et al., Gastrointestinal side effects in chronic opioid users: results from a population‐based survey. Alimentary pharmacology & therapeutics, 2008. 27(12): p. 1224-1232.
9. Kulich, K.R., et al., Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health and quality of life outcomes, 2008. 6(1): p. 1-12.
10. Locke III, G.R., et al., Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Official journal of the American College of Gastroenterology| ACG, 2004. 99(2): p. 350-357.
11. Mahajan, R., et al., Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity. Intestinal research, 2020. 18(2): p. 238.
12. Holzer, P., Opioid receptors in the gastrointestinal tract. Regulatory peptides, 2009. 155(1-3): p. 11-17.
13. Jehangir, A. and H.P. Parkman, Chronic opioids in gastroparesis: relationship with gastrointestinal symptoms, healthcare utilization and employment. World journal of gastroenterology, 2017. 23(40): p. 7310.
- Abstract Viewed: 31 times
